West Pharma (WST) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
West Announces First Quarter 2015 Results
April 30, 2015 7:01 AM EDTEXTON, PA -- (Marketwired) -- 04/30/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2015 and updated financial guidance for the full year 2015.
Highlights
Improved sales mix fuels wider gross margin and 21.6% growth in operating profit First-quarter diluted EPS rose 18.4% to $0.45 per share Reported sales declined 3.1% due to currency 6.5% growth in net sales at constant currency(1) Maintains 2015 constant currency sales growth estimate in the range of 6% to 8% Reported sales expected to be 1% to 2% lower Narrows... More


